317450 - Myungin Pharm

317450 Summary
Biopharma
Stock Price & Overview
₩44,650 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩44,650  ≈ US$32  ·  Market cap ₩0.7tn (≈ $466m)

Quarterly Report

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 분기보고서 (2026.03)